ISPIRE TECHNOLOGY INC Stock Price, News & Analysis

Ispire Technology Inc. (NASDAQ: ISPR) has issued a clarification regarding its Malaysian subsidiary's operations, emphasizing full compliance with local regulations. The company confirmed that its Johor facility exclusively manufactures vaporizer hardware for export, with no local distribution or production of nicotine/cannabis-containing products. Key points include: strict export-only manufacturing protocols, production limited to semi-finished vaporizer hardware without liquids or gels, and planned integration of blockchain-based safety features including age-gating and geo-fencing technology. The company has committed over USD 50 million in investment to establish a premier manufacturing hub in Southeast Asia. Ispire also clarified that recent cannabis-related product references pertained only to U.S. operations where such products are legal, not Malaysian activities.

Ispire Technology (NASDAQ: ISPR), a leader in vaping technology and precision dosing, will participate in the Benzinga Cannabis Capital Conference in Chicago on June 10-11, 2025. Dennis Lider, SVP of Cannabis, will join a panel discussion titled 'The Hidden Winners in Cannabis: Profitable Businesses Without the Red Tape' focusing on successful ancillary cannabis companies. The announcement follows a significant milestone where IKE Tech, Ispire's joint venture, received an FDA Acceptance Review letter for its blockchain-enabled age-gating system PMTA, advancing to the filing review phase. The panel, scheduled for June 10 at 11:00 am CDT, will feature executives from Rx Green Technologies, HARA Supply, and Grove Bags, discussing opportunities in the cannabis industry without direct plant-touching operations.

Ispire Technology (NASDAQ: ISPR) announced that IKE Tech, its joint venture, will present at the 7th Annual Next Generation Nicotine Delivery USA Conference in Miami. The presentation follows IKE Tech's groundbreaking PMTA filing with the FDA for a Bluetooth Low Energy System-on-a-Chip featuring blockchain-enabled age verification for ENDS devices. This marks the first complete PMTA submission for a universal, interoperable age-verification component. John Patterson, SVP of International Nicotine at Ispire and IKE Tech president, will discuss youth vaping challenges and their technology solution at a panel on June 4. The system implements continuous, real-time identity verification, going beyond traditional point-of-purchase age checks. IKE Tech has received an Acceptance Review letter from the FDA and requested expedited review citing public health benefits.

Ispire Technology Inc. (NASDAQ: ISPR) has secured a groundbreaking interim license from the Malaysian Government for nicotine product manufacturing. The company becomes the first and only entity in Malaysia with comprehensive authorization for export, import, and production of nicotine products.

The interim license enables immediate commencement of manufacturing operations. Ispire plans to expand its Malaysian facility from the current 6 production lines to 80 lines. The company expects to receive the final license in the coming months, completing its regulatory requirements in Malaysia.

This strategic move aims to diversify Ispire's production base and mitigate geopolitical pricing risks, positioning the company as a leading international vaping hardware provider.

Ispire Technology (NASDAQ: ISPR) has appointed Jie "Jay" Yu as its new Chief Financial Officer, effective immediately, following Jim McCormick's departure. Yu, who has served as VP of Finance since June 2023, brings extensive experience in public accounting, including roles at Crowe Horwath and previous CFO positions at MTI Environmental Group and Luokung Technology. Alongside this appointment, Ispire announced significant cost-cutting measures, including a $3.6 million reduction in annual payroll through workforce reductions and contractor terminations in May 2025. The company plans to cut an additional $6.6 million in operating expenses over the next three months, targeting total annual cost savings of $10.2 million in fiscal 2025. These strategic moves align with Ispire's focus on becoming a global provider of precision dosing vaping technology while improving profitability through operational streamlining and transitioning certain operations to Malaysia.

Ispire Technology (NASDAQ: ISPR) reported its Q3 FY2025 financial results, showing revenue of $26.2M, down 12.7% from $30.0M in Q3 FY2024. The company posted a net loss of $10.9M ($0.19 per share), compared to a $5.9M loss in the prior year. Key highlights include: accounts receivable reduction to $60.4M from $67.7M, transition of manufacturing to Malaysia with expected $8M annual operating cost savings, and receipt of an interim license for nicotine manufacturing in Malaysia. The company also filed a component PMTA with FDA through IKE Tech for blockchain-based age-gating technology and launched Sprout™, an advanced cannabis vapor device, in partnership with Raw Garden. Gross margin decreased to 18.2% from 20.4% year-over-year, while operating expenses increased to $15.4M from $11.8M.

Ispire Technology (NASDAQ: ISPR), a leader in vaping technology and precision dosing, has scheduled its fiscal third quarter 2025 earnings conference call for Monday, May 12, 2025, at 8:00 AM ET. The call will discuss financial results for the quarter ended March 31, 2025.

Participants can join via phone using North America (888-880-3330) or International (+1 646-357-8766) dial-in numbers. A webcast will be available at https://app.webinar.net/z9kqo2ro81l. A replay will be accessible until May 15, 2025, using 800-770-2030 (Toll Free) or 609-800-9909 (Toll) with passcode 9733287.

Ispire Technology (NASDAQ: ISPR) has announced a groundbreaking development in vaping safety through its joint venture IKE Tech. The company has filed the first-ever PMTA and TPMF with the FDA for a blockchain-enabled age-verification system designed for ENDS devices. The innovative BLE System-on-a-Chip requires continuous, real-time age verification for device access, achieving 100% effectiveness in preventing underage usage and demographic verification in testing.

The technology demonstrated impressive results in Human Factors Validation Study, including user error rates below 1% and 91% user satisfaction. IKE Tech has requested expedited FDA review, citing public health benefits. The submission follows a successful pre-PMTA meeting with the FDA in Q4 2024, where regulators showed openness to component-based PMTAs.

The system aims to create an FDA-authorized standard for youth prevention while maintaining adult access to reduced-risk alternatives, potentially opening new pathways for flavored vaping products.

IKE Tech has filed the first-ever PMTA for a standalone blockchain-based age-gating system for vaping devices. The system combines Bluetooth Low Energy (BLE) technology with a mobile app for real-time age verification at point-of-use. A Human Factors validation study demonstrated 100% effectiveness in preventing device activation for users under 21, with 91% of users rating the app as "Extremely Easy" or "Very Easy" to use. The system features continuous verification requirements, blockchain-based tokenization for security, and is compatible with all ENDS devices. The technology showed a low 0.8% user error rate and successfully verified demographic data across all test cases.